BIOMAT Database Logo BIOMAT Database Logo

Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics. 1972

A R Nissenson, and N W Levin, and R H Parker

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A R Nissenson, and N W Levin, and R H Parker
Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure.
January 1982, Nephron,
A R Nissenson, and N W Levin, and R H Parker
The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis.
December 1997, Clinical pharmacology and therapeutics,
A R Nissenson, and N W Levin, and R H Parker
[Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
March 1984, Presse medicale (Paris, France : 1983),
A R Nissenson, and N W Levin, and R H Parker
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
July 1982, The American journal of medicine,
A R Nissenson, and N W Levin, and R H Parker
Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations.
April 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
A R Nissenson, and N W Levin, and R H Parker
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
December 2006, Clinical pharmacology and therapeutics,
A R Nissenson, and N W Levin, and R H Parker
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.
November 1966, The Journal of clinical investigation,
A R Nissenson, and N W Levin, and R H Parker
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
September 1981, Antimicrobial agents and chemotherapy,
A R Nissenson, and N W Levin, and R H Parker
The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene.
February 1996, Journal of clinical pharmacology,
A R Nissenson, and N W Levin, and R H Parker
Chronic renal failure: effect of hemodialysis on gastrointestinal hormones.
December 1984, American journal of surgery,
Copied contents to your clipboard!